Belite Bio, Inc Convertible Preferred Stock Converted to Other Securities
Belite Bio, Inc (BLTE) reported Convertible Preferred Stock Converted to Other Securities of $31.81 million for the 12-month period ending 2022-12-31, per its 20-F filed 2025-03-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ConvertiblePreferredStockConvertedToOtherSecurities · last filed 2025-03-17
| Period end | Convertible Preferred Stock Converted to Other Securities 12 month |
|---|---|
| 2022-12-31 | $31.81M 20-F · filed 2025-03-17 |